AKT1 and colitis: Treatment of 50 mg/kg LBP significantly increased the relative abundance of Lactobacillus brevis at the species level in high-fat diet induced mice, and Lactobacillus brevis displayed the function of anti-colitis by inhibiting NF-κB, MAPK, and AKT pathways [32].